Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

KAPA Kairos Pharma Ltd

1,374

-0,076 (-5,24%)

15 Feb 2025 - Geschlossen

Verzögert um 15 Minuten

Form 3 - Initial statement of beneficial ownership of securities

Kairos Pharma (AMEX:KAPA)
Historical Stock Chart
Von Jan 2025 bis Feb 2025

Click Here for more Kairos Pharma Charts.

Kairos Pharma (AMEX:KAPA)
Historical Stock Chart
Von Feb 2024 bis Feb 2025

Click Here for more Kairos Pharma Charts.

News Kairos Pharma Ltd

Kairos Pharma Adds Huntsman Cancer Institute for Phase 2 ENV105 Clinical Trial
Dienstag 11 Februar 2025 (7 Tage vor) • Business Wire

Form DEF 14C - Other definitive information statements
Montag 10 Februar 2025 (1 Woche vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 6 Februar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Kairos Pharma Oral Presentation on Its Investigational Compound KROS 101 at the 13th AACR-JCA Joint Conference Supports the Compound’s Potential as a Therapeutic for Melanoma and Glioblastoma
Donnerstag 6 Februar 2025 (2 Wochen vor) • Business Wire

Form 424B3 - Prospectus [Rule 424(b)(3)]
Mittwoch 5 Februar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Mittwoch 5 Februar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form PRE 14C - Other preliminary information statements
Mittwoch 29 Januar 2025 (3 Wochen vor) • Edgar (US Regulatory)

Form S-1 - General form for registration of securities under the Securities Act of 1933
Mittwoch 29 Januar 2025 (3 Wochen vor) • Edgar (US Regulatory)

Kairos Pharma to Present Short Talk on Its Investigational Compound KROS 101 at the 13th AACR-JCA Joint Conference February 5, 2024
Dienstag 28 Januar 2025 (3 Wochen vor) • Business Wire

Kairos Pharma Provides Business Update and Outlook into 2025
Dienstag 21 Januar 2025 (4 Wochen vor) • Business Wire

Form 8-K - Current report
Freitag 17 Januar 2025 (1 Monat vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 14 Januar 2025 (1 Monat vor) • Edgar (US Regulatory)

Weitere Kairos Pharma Ltd News-Artikel

Therapeutic Solutions (PK)

Jsc.nc Kaz 43 S

PT Indosat Tbk (PK)

Sefton Resources

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen